BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30645056)

  • 1. Holo-Lactoferrin Modified Liposome for Relieving Tumor Hypoxia and Enhancing Radiochemotherapy of Cancer.
    Zhang Z; Yang J; Min Q; Ling C; Maiti D; Xu J; Qin L; Yang K
    Small; 2019 Feb; 15(6):e1803703. PubMed ID: 30645056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinoma.
    Wei M; Guo X; Tu L; Zou Q; Li Q; Tang C; Chen B; Xu Y; Wu C
    Int J Nanomedicine; 2015; 10():5123-37. PubMed ID: 26316745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer.
    Zhang Z; Lu M; Chen C; Tong X; Li Y; Yang K; Lv H; Xu J; Qin L
    Theranostics; 2021; 11(7):3167-3182. PubMed ID: 33537080
    [No Abstract]   [Full Text] [Related]  

  • 4. Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas.
    Chen H; Qin Y; Zhang Q; Jiang W; Tang L; Liu J; He Q
    Eur J Pharm Sci; 2011 Sep; 44(1-2):164-73. PubMed ID: 21782939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma targeting effect of PEGylated liposomes modified with lactoferrin.
    Wei M; Xu Y; Zou Q; Tu L; Tang C; Xu T; Deng L; Wu C
    Eur J Pharm Sci; 2012 Jun; 46(3):131-41. PubMed ID: 22369856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a hypoxia-triggered and hypoxic radiosensitized liposome as a doxorubicin carrier to promote synergetic chemo-/radio-therapy for glioma.
    Liu H; Xie Y; Zhang Y; Cai Y; Li B; Mao H; Liu Y; Lu J; Zhang L; Yu R
    Biomaterials; 2017 Mar; 121():130-143. PubMed ID: 28088075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxic tumor therapy by hemoglobin-mediated drug delivery and reversal of hypoxia-induced chemoresistance.
    Yang J; Li W; Luo L; Jiang M; Zhu C; Qin B; Yin H; Yuan X; Yin X; Zhang J; Luo Z; Du Y; You J
    Biomaterials; 2018 Nov; 182():145-156. PubMed ID: 30121013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel lactoferrin-modified stealth liposome for hepatoma-delivery of triiodothyronine.
    Pireddu R; Pibiri M; Valenti D; Sinico C; Fadda AM; Simbula G; Lai F
    Int J Pharm; 2018 Feb; 537(1-2):257-267. PubMed ID: 29294323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery.
    Chen H; Tang L; Qin Y; Yin Y; Tang J; Tang W; Sun X; Zhang Z; Liu J; He Q
    Eur J Pharm Sci; 2010 May; 40(2):94-102. PubMed ID: 20298779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactoferrin-conjugated biodegradable polymersome holding doxorubicin and tetrandrine for chemotherapy of glioma rats.
    Pang Z; Feng L; Hua R; Chen J; Gao H; Pan S; Jiang X; Zhang P
    Mol Pharm; 2010 Dec; 7(6):1995-2005. PubMed ID: 20957995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalase-loaded cisplatin-prodrug-constructed liposomes to overcome tumor hypoxia for enhanced chemo-radiotherapy of cancer.
    Zhang R; Song X; Liang C; Yi X; Song G; Chao Y; Yang Y; Yang K; Feng L; Liu Z
    Biomaterials; 2017 Sep; 138():13-21. PubMed ID: 28550753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pH-sensitive hyaluronic acid prodrug modified with lactoferrin for glioma dual-targeted treatment.
    Yin Y; Fu C; Li M; Li X; Wang M; He L; Zhang LM; Peng Y
    Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():159-169. PubMed ID: 27287110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extremely Effective Chemoradiotherapy by Inducing Immunogenic Cell Death and Radio-Triggered Drug Release under Hypoxia Alleviation.
    Zhu C; Guo X; Luo L; Wu Z; Luo Z; Jiang M; Zhang J; Qin B; Shi Y; Lou Y; Qiu Y; You J
    ACS Appl Mater Interfaces; 2019 Dec; 11(50):46536-46547. PubMed ID: 31751119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of Tumor Microenvironment-Responsive Drug-Drug Micelle for Cancer Radiochemotherapy.
    Mao H; Xie Y; Ju H; Mao H; Zhao L; Wang Z; Hua L; Zhao C; Li Y; Yu R; Liu H
    ACS Appl Mater Interfaces; 2018 Oct; 10(40):33923-33935. PubMed ID: 30205681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin-loaded nanocarriers: A comparative study of liposome and nanostructured lipid carrier as alternatives for cancer therapy.
    Fernandes RS; Silva JO; Monteiro LOF; Leite EA; Cassali GD; Rubello D; Cardoso VN; Ferreira LAM; Oliveira MC; de Barros ALB
    Biomed Pharmacother; 2016 Dec; 84():252-257. PubMed ID: 27664949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derma rollerĀ® microneedles-mediated transdermal delivery of doxorubicin and celecoxib co-loaded liposomes for enhancing the anticancer effect.
    Ahmed KS; Shan X; Mao J; Qiu L; Chen J
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():1448-1458. PubMed ID: 30889679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
    Li X; Ding L; Xu Y; Wang Y; Ping Q
    Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel cancer targeting approach based on estrone anchored stealth liposome for site-specific breast cancer therapy.
    Paliwal SR; Paliwal R; Mishra N; Mehta A; Vyas SP
    Curr Cancer Drug Targets; 2010 May; 10(3):343-53. PubMed ID: 20370682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocytosis and degradation of bovine apo- and holo-lactoferrin by isolated rat hepatocytes are mediated by recycling calcium-dependent binding sites.
    McAbee DD; Nowatzke W; Oehler C; Sitaram M; Sbaschnig E; Opferman JT; Carr J; Esbensen K
    Biochemistry; 1993 Dec; 32(49):13749-60. PubMed ID: 8257710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octreotide-modification enhances the delivery and targeting of doxorubicin-loaded liposomes to somatostatin receptors expressing tumor in vitro and in vivo.
    Sun M; Wang Y; Shen J; Xiao Y; Su Z; Ping Q
    Nanotechnology; 2010 Nov; 21(47):475101. PubMed ID: 21030757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.